Alcon issued a global recall of CyPass Micro-Stent and advised surgeons to immediately stop implanting the device in patients after reviewing long-term safety data, Verdict Medical Devices reports. 1.

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The Food and Drug Administration recently approved the CyPass Micro-Stent for the treatment of glaucoma. The stent, produced by Fort Worth, Texas-based Alcon, is a micro-invasive surgical device used ...

Glaucoma is a disease of the optic nerve that can lead to vision loss and permanent blindness. Without proper treatment, a person with glaucoma loses peripheral vision first, followed by the loss of ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...

New minimally invasive glaucoma treatments, including stents placed during cataract surgery and long-acting eye implants, are now available in Cape May County, reducing reliance on daily eye drops.

Ophthalmic research focus grows around glaucoma therapy and device development Webinar spotlight covers BL therapy and ELIOS surgical platform technology Sector discussion expands alongside activity ...

Microscopic imaging of trabecular meshwork cells, which play a critical role regulating intraocular pressure. To better understand how the cells function, researchers use fluorescent stains to mark ...

Several different types of eye surgery exist, including laser or traditional surgery and minimally invasive options. The specific treatment you need depends on many factors such as your eye condition ...

MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...